Abstract:Fusarium species are saprophytic organisms that are widely distributed in soil and plants. They can cause superficial, invasive, or disseminated fusariosis in immunocompromised and immunocompetent subjects.1Nucci M. Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management.Clin Infect Dis. 2002; 35: 909-920Crossref PubMed Scopus (319) Google Scholar Cutaneous fusariosis is characterized by papulopustular lesions with abscesses, ulcerations, and even necrosis. Most immunocompetent patients with cutaneous fusariosis respond well to antifungal therapy.2Dignani M.C. Anaissie E. Human fusariosis.Clin Microbiol Infect. 2004; 10: 67-75Crossref PubMed Scopus (284) Google ScholarHere we report the case of a 7-year-old girl with cutaneous fusariosis recalcitrant to therapy. Using exome sequencing for this patient, we identified a de novo missense mutation in the signal transducer and activator of transcription 1 (STAT1) gene, the mutation of which was previously known to cause autosomal dominant chronic mucocutaneous candidiasis (CMC).3Liu L. Okada S. Kong X.F. Kreins A.Y. Cypowyj S. Abhyankar A. et al.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011; 208: 1635-1648Crossref PubMed Scopus (569) Google ScholarA 7-year-old Han Chinese girl presented with progressive red verrucous plaques and nodules with ulcerations, exudates, and coarse crusts predominating on her nose, cheeks, right hand, and the inner side of her right knee for more than 6 years (Fig 1, A and B). The lesions were first noticed around her right knee and cheeks after she fell on the floor when she was 11 months old and then involved her right hand 3 years later without traumatic injury.The patient was of full-term normal delivery, with nonconsanguineous marriage of her parents. Family history revealed no members with relevant fungal infectious diseases or immunodeficiencies. She had mild malnutrition and developed normal intelligence. The results of all laboratory examinations, including complete blood count, lymphocyte subsets, serum immunoglobulin levels, and serum complement levels, were normal. Histopathology of the lesions revealed mixed inflammatory cells infiltrating throughout the dermis. Numerous branching hyphae were noted in the stratum corneum with periodic acid–Schiff staining (Fig 1, C). Fusarium solani was isolated from the tissue cultures and identified based on morphologic features (Fig 1, D), and this was further supported by internal transcribed spacer region nucleotide sequencing. On the basis of all the above findings, we made a diagnosis of cutaneous fusariosis caused by F solani.The patient had received different systemic antifungal treatments in the past 5 years, including fluconazol, itraconazole and terbinafine, amphotericin B, and voriconazole. In addition, intramuscular injection of thymopentin, topical antifungal agents, and local heat therapy were also applied since 1.5 years ago, but the lesions were extremely intractable with slow progression.Because of the early onset of the disease and the resistance to antifungal treatment, a genetic defect concerning immune response to fungal infections was hypothesized. Written informed consent was obtained from the parents for molecular genetic studies according to the rules from the Clinical Research Ethics Committee of the Peking University First Hospital.We applied a genome-wide approach and sequenced the exome of the patient (Beijing Genomic Institute, Shenzhen, China). Exome capture was carried out with the SureSelect Human All Exon Kit (Agilent, Santa Clara, Calif), according to the manufacturer's protocols, and then sequenced with the Hiseq2000 platform (Illumina, San Diego, Calif). Single nucleotide variations of the patient were filtered by using the dbSNP134, 1000 Genomes Project, and HapMap8 databases, with 1006 variants left, involving 772 genes. When we compared the data with all the genes reported to be related to fungal infections (see Table E1 in this article's Online Repository at www.jacionline.org),4Romani L. Immunity to fungal infections.Nat Rev Immunol. 2011; 11: 275-288Crossref PubMed Scopus (851) Google Scholar only 1 heterozygous missense mutation c.604A>G (p.M202V) in the STAT1 gene was noted. Sanger sequencing confirmed the STAT1 mutation in the patient. The same variation was not found in her parents, which indicated a de novo mutation (see Fig E1 in this article's Online Repository at www.jacionline.org). This mutation was not detected in 200 ethnically matched healthy control subjects, and the parentage of the patient-parent trio was confirmed by using a panel of microsatellite markers. On the basis of the rarity of de novo mutations (<1 per exome)5Lynch M. Rate, molecular spectrum, and consequences of human mutation.Proc Natl Acad Sci U S A. 2010; 107: 961-968Crossref PubMed Scopus (500) Google Scholar and the previous report of c.604A>G mutation in 3 cases of CMC from 2 kindreds,3Liu L. Okada S. Kong X.F. Kreins A.Y. Cypowyj S. Abhyankar A. et al.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011; 208: 1635-1648Crossref PubMed Scopus (569) Google Scholar this variant was most likely to be the genetic defect underlying the fusariosis in this patient.STAT1, one of the 7 transcription factors of the STAT family and major signaling components of interferon responses, is activated by tyrosine phosphorylation when interferons bind to their receptors.6Najjar I. Fagard R. STAT1 and pathogens, not a friendly relationship.Biochimie. 2010; 92: 425-444Crossref PubMed Scopus (91) Google Scholar By forming a dimer, STAT1 enters the nucleus and triggers the transcription of its targets, which plays a pivotal role in the defense against pathogens. Different types of STAT1 mutations underlie different sets of infectious diseases, including complete or partial STAT1 deficiency with autosomal recessive inheritance in life-threatening or milder intracellular bacterial and viral diseases, autosomal dominant STAT1 deficiency in Mendelian susceptibility to mycobacterial disease, and autosomal dominant gain of STAT1 activity in patients with CMC and autoimmunity.7Boisson-Dupuis S. Kong X.F. Okada S. Cypowyj S. Puel A. Abel L. et al.Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes.Curr Opin Immunol. 2012; 24: 364-378Crossref PubMed Scopus (189) Google Scholar Heterozygous missense mutations in the coiled-coil domain of STAT1 were first reported in 14 patients with autosomal dominant CMC from 5 families by van de Veerdonk et al,8van de Veerdonk F.L. Plantinga T.S. Hoischen A. Smeekens S.P. Joosten L.A. Gilissen C. et al.STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.N Engl J Med. 2011; 365: 54-61Crossref PubMed Scopus (483) Google Scholar who subsequently reported 2 other families with CMC harboring known mutations in a latter publication.9Smeekens S.P. Plantinga T.S. van de Veerdonk F.L. Heinhuis B. Hoischen A. Joosten L.A. et al.STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis.PLoS One. 2011; 6: e29248Crossref PubMed Scopus (91) Google Scholar They demonstrated that patients had deficiencies in mounting TH1 and TH17 responses because of defective IL-12 receptor and IL-23 receptor signaling pathways.Liu et al3Liu L. Okada S. Kong X.F. Kreins A.Y. Cypowyj S. Abhyankar A. et al.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011; 208: 1635-1648Crossref PubMed Scopus (569) Google Scholar reported 12 different heterozygous STAT1 coiled-coil domain missense mutations, including p.M202V, in 47 patients from 20 families with autosomal dominant CMC. All the mutations were shown to be gain-of-function mutations, because of a gain of phosphorylation and a loss of nuclear dephosphorylation. The study found a profound defect in the development of IL-17–producing T cells ex vivo and in vitro. Our patient had some clinical features similar to the patients with CMC, including opportunistic cutaneous fungal infection since infancy and slowly progressive lesions with unsatisfactory therapeutic effect.On the basis of all these studies and findings, it is conceivable that the mutant STAT1 might also function in a dominant-positive manner to predispose our patient to cutaneous fusariosis. It is intriguing that no Candida species infection was experienced in our patient despite its ubiquity in human epithelium, which implicates, in addition to genetic predisposition, that other factors might also be involved in the pathogenic mechanisms. To the best of our knowledge, this is the first report of cutaneous fungal infections other than candidiasis related to STAT1 mutation. Our findings open new doors to understanding genetic predispositions to refractory, early-onset, cutaneous fungal infections. Fusarium species are saprophytic organisms that are widely distributed in soil and plants. They can cause superficial, invasive, or disseminated fusariosis in immunocompromised and immunocompetent subjects.1Nucci M. Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management.Clin Infect Dis. 2002; 35: 909-920Crossref PubMed Scopus (319) Google Scholar Cutaneous fusariosis is characterized by papulopustular lesions with abscesses, ulcerations, and even necrosis. Most immunocompetent patients with cutaneous fusariosis respond well to antifungal therapy.2Dignani M.C. Anaissie E. Human fusariosis.Clin Microbiol Infect. 2004; 10: 67-75Crossref PubMed Scopus (284) Google Scholar Here we report the case of a 7-year-old girl with cutaneous fusariosis recalcitrant to therapy. Using exome sequencing for this patient, we identified a de novo missense mutation in the signal transducer and activator of transcription 1 (STAT1) gene, the mutation of which was previously known to cause autosomal dominant chronic mucocutaneous candidiasis (CMC).3Liu L. Okada S. Kong X.F. Kreins A.Y. Cypowyj S. Abhyankar A. et al.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011; 208: 1635-1648Crossref PubMed Scopus (569) Google Scholar A 7-year-old Han Chinese girl presented with progressive red verrucous plaques and nodules with ulcerations, exudates, and coarse crusts predominating on her nose, cheeks, right hand, and the inner side of her right knee for more than 6 years (Fig 1, A and B). The lesions were first noticed around her right knee and cheeks after she fell on the floor when she was 11 months old and then involved her right hand 3 years later without traumatic injury. The patient was of full-term normal delivery, with nonconsanguineous marriage of her parents. Family history revealed no members with relevant fungal infectious diseases or immunodeficiencies. She had mild malnutrition and developed normal intelligence. The results of all laboratory examinations, including complete blood count, lymphocyte subsets, serum immunoglobulin levels, and serum complement levels, were normal. Histopathology of the lesions revealed mixed inflammatory cells infiltrating throughout the dermis. Numerous branching hyphae were noted in the stratum corneum with periodic acid–Schiff staining (Fig 1, C). Fusarium solani was isolated from the tissue cultures and identified based on morphologic features (Fig 1, D), and this was further supported by internal transcribed spacer region nucleotide sequencing. On the basis of all the above findings, we made a diagnosis of cutaneous fusariosis caused by F solani. The patient had received different systemic antifungal treatments in the past 5 years, including fluconazol, itraconazole and terbinafine, amphotericin B, and voriconazole. In addition, intramuscular injection of thymopentin, topical antifungal agents, and local heat therapy were also applied since 1.5 years ago, but the lesions were extremely intractable with slow progression. Because of the early onset of the disease and the resistance to antifungal treatment, a genetic defect concerning immune response to fungal infections was hypothesized. Written informed consent was obtained from the parents for molecular genetic studies according to the rules from the Clinical Research Ethics Committee of the Peking University First Hospital. We applied a genome-wide approach and sequenced the exome of the patient (Beijing Genomic Institute, Shenzhen, China). Exome capture was carried out with the SureSelect Human All Exon Kit (Agilent, Santa Clara, Calif), according to the manufacturer's protocols, and then sequenced with the Hiseq2000 platform (Illumina, San Diego, Calif). Single nucleotide variations of the patient were filtered by using the dbSNP134, 1000 Genomes Project, and HapMap8 databases, with 1006 variants left, involving 772 genes. When we compared the data with all the genes reported to be related to fungal infections (see Table E1 in this article's Online Repository at www.jacionline.org),4Romani L. Immunity to fungal infections.Nat Rev Immunol. 2011; 11: 275-288Crossref PubMed Scopus (851) Google Scholar only 1 heterozygous missense mutation c.604A>G (p.M202V) in the STAT1 gene was noted. Sanger sequencing confirmed the STAT1 mutation in the patient. The same variation was not found in her parents, which indicated a de novo mutation (see Fig E1 in this article's Online Repository at www.jacionline.org). This mutation was not detected in 200 ethnically matched healthy control subjects, and the parentage of the patient-parent trio was confirmed by using a panel of microsatellite markers. On the basis of the rarity of de novo mutations (<1 per exome)5Lynch M. Rate, molecular spectrum, and consequences of human mutation.Proc Natl Acad Sci U S A. 2010; 107: 961-968Crossref PubMed Scopus (500) Google Scholar and the previous report of c.604A>G mutation in 3 cases of CMC from 2 kindreds,3Liu L. Okada S. Kong X.F. Kreins A.Y. Cypowyj S. Abhyankar A. et al.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011; 208: 1635-1648Crossref PubMed Scopus (569) Google Scholar this variant was most likely to be the genetic defect underlying the fusariosis in this patient. STAT1, one of the 7 transcription factors of the STAT family and major signaling components of interferon responses, is activated by tyrosine phosphorylation when interferons bind to their receptors.6Najjar I. Fagard R. STAT1 and pathogens, not a friendly relationship.Biochimie. 2010; 92: 425-444Crossref PubMed Scopus (91) Google Scholar By forming a dimer, STAT1 enters the nucleus and triggers the transcription of its targets, which plays a pivotal role in the defense against pathogens. Different types of STAT1 mutations underlie different sets of infectious diseases, including complete or partial STAT1 deficiency with autosomal recessive inheritance in life-threatening or milder intracellular bacterial and viral diseases, autosomal dominant STAT1 deficiency in Mendelian susceptibility to mycobacterial disease, and autosomal dominant gain of STAT1 activity in patients with CMC and autoimmunity.7Boisson-Dupuis S. Kong X.F. Okada S. Cypowyj S. Puel A. Abel L. et al.Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes.Curr Opin Immunol. 2012; 24: 364-378Crossref PubMed Scopus (189) Google Scholar Heterozygous missense mutations in the coiled-coil domain of STAT1 were first reported in 14 patients with autosomal dominant CMC from 5 families by van de Veerdonk et al,8van de Veerdonk F.L. Plantinga T.S. Hoischen A. Smeekens S.P. Joosten L.A. Gilissen C. et al.STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.N Engl J Med. 2011; 365: 54-61Crossref PubMed Scopus (483) Google Scholar who subsequently reported 2 other families with CMC harboring known mutations in a latter publication.9Smeekens S.P. Plantinga T.S. van de Veerdonk F.L. Heinhuis B. Hoischen A. Joosten L.A. et al.STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis.PLoS One. 2011; 6: e29248Crossref PubMed Scopus (91) Google Scholar They demonstrated that patients had deficiencies in mounting TH1 and TH17 responses because of defective IL-12 receptor and IL-23 receptor signaling pathways. Liu et al3Liu L. Okada S. Kong X.F. Kreins A.Y. Cypowyj S. Abhyankar A. et al.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.J Exp Med. 2011; 208: 1635-1648Crossref PubMed Scopus (569) Google Scholar reported 12 different heterozygous STAT1 coiled-coil domain missense mutations, including p.M202V, in 47 patients from 20 families with autosomal dominant CMC. All the mutations were shown to be gain-of-function mutations, because of a gain of phosphorylation and a loss of nuclear dephosphorylation. The study found a profound defect in the development of IL-17–producing T cells ex vivo and in vitro. Our patient had some clinical features similar to the patients with CMC, including opportunistic cutaneous fungal infection since infancy and slowly progressive lesions with unsatisfactory therapeutic effect. On the basis of all these studies and findings, it is conceivable that the mutant STAT1 might also function in a dominant-positive manner to predispose our patient to cutaneous fusariosis. It is intriguing that no Candida species infection was experienced in our patient despite its ubiquity in human epithelium, which implicates, in addition to genetic predisposition, that other factors might also be involved in the pathogenic mechanisms. To the best of our knowledge, this is the first report of cutaneous fungal infections other than candidiasis related to STAT1 mutation. Our findings open new doors to understanding genetic predispositions to refractory, early-onset, cutaneous fungal infections. We thank the patient and her family members for participation in this study. Supplementary data Download .jpg (.16 MB) Help with files Fig E1 Download .doc (.28 MB) Help with doc files Table E1 Download .jpg (.16 MB) Help with files Fig E1 Download .doc (.28 MB) Help with doc files Table E1

Abstract:Phaeohyphomycosis is a group of superficial, cutaneous, subcutaneous, or systemic infections caused by more than 100 species of diverse dematiaceous fungi. It is characterized by dematiaceous yeast-like cells, hyphae, and pseudohyphae in tissue, while sclerotic bodies, characteristics of chromoblastomycosis, are absent.1Li R.Y. Wang D.L. Studies on phaeohyphomycosis and its causative agents in China.Jpn J Med Mycol. 1996; 37: 135-141Crossref Scopus (16) Google Scholar Phialophora verrucosa, one of the Phialophora species, can be isolated from soil, wood, and rotting vegetation worldwide and has sometimes been reported to cause subcutaneous phaeohyphomycosis.2Gao L.J. Yu J. Wang D.L. Li R.Y. Recalcitrant primary subcutaneous phaeohyphomycosis due to Phialophora verrucosa.Mycopathologia. 2013; 175: 165-170Crossref PubMed Scopus (10) Google Scholar During the last decade, host defense against fungal infections has been extensively studied. Our understanding of genetic and immune deficiencies that predispose to chronic mucocutaneous candidiasis has substantially advanced.3Engelhardt K.R. Grimbacher B. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects.J Allergy Clin Immunol. 2012; 129 (306-7): 294-305Abstract Full Text Full Text PDF PubMed Scopus (55) Google Scholar However, the genetic and immunologic defects in patients with phaeohyphomycosis have not been investigated. Here, we report 4 Chinese patients with subcutaneous phaeohyphomycosis caused by P verrucosa with CARD9 mutations and TH17 cell deficiencies. Four patients presenting with persistent red plaques and nodules on their cheeks and faces were recruited in our study (Fig 1, A-C). The clinical manifestations and the outcomes of the 4 patients are summarized in Table E1 in this article's Online Repository at www.jacionline.org. Histological examination revealed intense inflammatory infiltrations with dematiaceous hyphae (Fig 1, D). From tissue cultures, P verrucosa was isolated and identified by the morphological characteristics of black colonies in macroscopic appearance and septate hyphae with typical Phialophora type of sporulation in microscopic appearance (Fig 1, E and F), which was confirmed by internal transcribed spacer region nucleotide sequencing (Genbank Accession No. KF360974, KF471126, KF360975, and JX233482). There were no other chronic or opportunistic infections detected or reported in all the patients before their presentation, and they could not recall any trauma. A history of consanguineous marriage was denied. The diagnosis of phaeohyphomycosis caused by P verrucosa was made on the basis of the above clinical, histopathological, and mycological findings. As is known, both chromoblastomycosis and phaeohyphomycosis can be caused by dematiaceous fungi, but the clinical manifestations and prognosis are different.1Li R.Y. Wang D.L. Studies on phaeohyphomycosis and its causative agents in China.Jpn J Med Mycol. 1996; 37: 135-141Crossref Scopus (16) Google Scholar Patients with P verrucosa–associated subcutaneous phaeohyphomycosis, as demonstrated in our cases, have a relatively early onset, no trauma history, and no known immunocompromised conditions and are resistant to various systemic antifungal agents with remittent aggravation. These clinical features highly suggest that some underlying genetic defects and the subsequent immunodeficiencies should be considered, and thus we carried out whole-exome sequencing in 2 of the sporadic cases (patients 1 and 2). Written informed consent was obtained from all the patients and 6 ethnically matched healthy volunteers. Ethical approval for molecular genetic studies was obtained from the Clinical Research Ethics Committee of Peking University First Hospital. Genomic DNA was extracted from the peripheral blood leukocytes. Exome capture was carried out with SureSelect Human All Exon Kit (Agilent, Santa Clara, Calif), and then sequenced by using Hiseq2000 platform. To eliminate the nonpathogenic variants, we filtered out the single nucleotide variants and short insertions and deletions (indels) existing in in-house database and 3 public variation databases (dbSNP134, 1000 Genomes Project, and HapMap8). As a result, including indels, 1333 variants involving 1000 different genes and 1220 variants involving 943 different genes were detected in patient 1 and patient 2, respectively. When we compared these variants with the genes previously reported to be implicated in fungal infection,4Wang X.W. Lin Z.M. Gao L.J. Wang A.P. Wan Z. Chen W. et al.Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis.J Allergy Clin Immunol. 2013; 131: 1242-1243Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar only 1 gene (CARD9) shared by both patients was found. Sanger sequencing was subsequently performed to validate these 3 variants involving CARD9 and to screen mutations of CARD9 in the other 2 patients. Briefly, 3 mutations of CARD9 were detected: 2 compound heterozygous mutations in patient 1 (c.191-192insTGCT and c.472C>T, p.L64fsX59 and p.Q158X) and 1 homozygous frameshift mutation (c.819-820insG, p.D274fsX60) in patients 2, 3, and 4 (see Fig E1, A, in this article's Online Repository at www.jacionline.org). No relationship or common relatives were reported in patients 2, 3, and 4, who were from different provinces and did not know each other before. We subsequently performed haplotype analysis in these 3 patients to determine whether mutation c.819-820insG was from one common ancestor. Twelve single nucleotide polymorphisms highly polymorphic in Asian populations nearby the mutation were chosen and genotyped. Unexpectedly, all 3 patients shared the same homozygous alleles in all 12 SNPs, suggesting a founder effect (see Table E2 in this article's Online Repository at www.jacionline.org). Parents and siblings of the patients were all healthy and heterozygous carriers of 1 corresponding mutation (the deceased parents of patients 3 and 4 were not enrolled; Fig E1, B). All these detected mutations were not found in 220 ethnically matched control subjects. Thus, CARD9 was selected as the most likely causative gene underlying phaeohyphomycosis in these patients. To verify the expression of CARD9 in our cases, we detected it in PBMCs of patients 1, 2, and 3 by using quantitative PCR and western blot. (Patient 4 was not enrolled in the following study because of traffic inconvenience.) Patients exhibited sufficient level of CARD9 mRNA transcripts compared with 5 healthy donors, thereby escaping from nonsense-mediated RNA decay (Fig E1, C). Contrarily, patients lacked the expression of the wild-type mature CARD9 protein, which further confirmed the consequences of premature termination codons in frameshift and nonsense mutations (Fig 2, A). CARD9 is a critical adaptor that can mediate Dectin-1, Dectin-2, and Mincle-induced NF-κB activation by forming the CARD9–BCL10–MALT1 complex in response to fungal infection.5Bertin J. Guo Y. Wang L. Srinivasula S.M. Jacobson M.D. Poyet J.L. et al.CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B.J Biol Chem. 2000; 275: 41082-41086Crossref PubMed Scopus (186) Google Scholar, 6Drummond R.A. Saijo S. Iwakura Y. Brown G.D. The role of Syk/CARD9 coupled C-type lectins in antifungal immunity.Eur J Immunol. 2011; 41: 276-281Crossref PubMed Scopus (161) Google Scholar CARD9 deficiencies may impair pivotal cytokine production in innate immune cells and the differentiation of TH17 cells. It was reported that CARD9-deficient mice were highly susceptible to Candida albicans infections.7Gross O. Gewies A. Finger K. Schafer M. Sparwasser T. Peschel C. et al.Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity.Nature. 2006; 442: 651-656Crossref PubMed Scopus (667) Google Scholar And homozygous loss-of-function nonsense mutation in CARD9 (Q295X) has been found to cause chronic mucocutaneous candidiasis in a large consanguineous family, with reduced TH17 cells and impaired immune response to Dectin-1 agonist.8Glocker E.O. Hennigs A. Nabavi M. Schaffer A.A. Woellner C. Salzer U. et al.A homozygous CARD9 mutation in a family with susceptibility to fungal infections.N Engl J Med. 2009; 361: 1727-1735Crossref PubMed Scopus (627) Google Scholar We then assessed the abundance of TH17 cells and the related cytokines in patients 1, 2, and 3. It was noteworthy in our observation that the percentages of TH17 cells (CD4+/IL-17+) in patients' PBLs were strikingly decreased, and so was the representative effector cytokines IL-17 and IL-22 in serum (Fig 2, B and C). The profound deficiencies of TH17 responses, as downstream consequences, might lead to the patients' suppressed antifungal immunity. As the key players in initiating and regulating adaptive immune responses, macrophages and dendritic cells (DCs) secrete cytokines to trigger the differentiation of TH17 cells.9Romani L. Immunity to fungal infections.Nat Rev Immunol. 2011; 11: 275-288Crossref PubMed Scopus (868) Google Scholar Therefore, we isolated monocytes from 3 healthy donors and patients 1 and 3, and induced them toward macrophages and immature DCs. Responses to P verrucosa spores were detected by the production of IL-6, TNF-α, IL-1β, and IL-23p19 in supernatants, which were essential for the differentiation, activation, and expansion of TH17 cells. When challenged with P verrucosa spores, both macrophages and DCs from patients secreted much lower cytokines than did those from control subjects (Fig 2, D and E). It is reasonable to speculate that CARD9 deficiencies cause the decreased production of cytokines from innate immune cells, which leads to the deficiencies of TH17 cells and consequently predisposes patients to recalcitrant subcutaneous P verrucosa infections. An intriguing feature of these patients is that distinct mutations in CARD9 did not give rise to Candida infections in our cases, despite its ubiquity in human skin. Whether CARD9 is indispensable in different fungal infections, as well as the association of genotype with phenotype, still needs further investigation. Taken together, our study showed CARD9 mutations in 4 patients with pheohyphomycosis with marked decreased proportions and cytokines of TH17 cells and impaired immune responses against P verrucosa, which further confirmed the pivotal role of CARD9 in antifungal defense. Our preliminary findings of P verrucosa linked, for the first time, CARD9 deficiencies with the susceptibility to opportunistic filamentous fungi, other than yeast or yeast-like fungi. What we have identified in this study will enrich the phenotypic spectrum of diseases underlying CARD9 deficiencies. We thank all of the patients and their family members for their participation in this study. We also thank Zhe Wan and Wei Chen for isolation and identification of the pathogen and Prof Dalong Ma, the director of Peking University Health Science Center, for supporting the project and advice on the paper. Table E1Summary of the clinical manifestations for the patientsPatientSexAge (y)Age at presentation (y)Clinical featuresOutcome1Male2113Progressive dark red plaques and nodules on his bilateral cheeks and earsOral itraconazole and intravenous amphotericin B once showed limited effect, but there was no complete healing. Now the lesions aggravated with subcutaneous disseminations.2Male176Gradually enlarged red plaques on his right cheekIntravenous amphotericin B followed by oral itraconazole for 2 y, with recurrence whenever withdrew the drug.3Female4320Slowly enlarged plaques and nodule on her right cheekSurgical excision of the nodule combined with oral itraconazole therapy for 1 y. It seemed effective, and she was still in treatment.4Male6448Severe violet plaque on his face and scalp, which involved his eyes and caused blindness 4 y agoOral itraconazole combined with terbinafine for half a year. The lesions improved slightly without satisfactory response. Open table in a new tab Table E2Haplotype analysis in patients 2, 3, and 4SNPLocation (hg19)Reference alleleAlternative alleleAllele frequency for samples from AsianPatient 2Patient 3Patient 4rs3812553Chr 9: 139256495GT0.10TTTrs10870201Chr 9: 139257147GC0.31CCCrs10870202Chr 9: 139257411TC0.32CCCrs45592338Chr 9: 139257422CG0.24GGGrs4073153Chr 9: 139259349AG0.31GGGrs3812555Chr 9: 139261933CT0.17TTTrs3812556Chr 9: 139261991AG0.24GGGrs59902911Chr 9: 139265088CT0.09TTTrs11145769Chr 9: 139265870GA0.10AAArs10781499Chr 9: 139266405GA0.30AAArs4077515Chr 9: 139266496CT0.31TTTrs4075760Chr 9: 139266697AG0.31GGG Open table in a new tab

An ACT1 Mutation Selectively Abolishes Interleukin-17 Responses in Humans with Chronic Mucocutaneous Candidiasis.

A Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis

Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency

Quantification of LVEF≤35% misclassification by 2D-echocardiography as compared to cardiac magnetic resonance in coronary artery disease: implications for AICD therapy

Exome Sequencing Reveals a Signal Transducer and Activator of Transcription 1 (STAT1) Mutation in a Child with Recalcitrant Cutaneous Fusariosis

Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity

Chinese Pedigree of Chronic Mucocutaneous Candidiasis Due to STAT1 Gain-of-Function Mutation: A Case Study and Literature Review

Altered Ligand-Interaction Contributes to Functional Insufficiency Due to CTLA-4 Gene Mutation

P110 AIRE Gene Mutation Predisposing Chronic Mucocutaneous Candidiasis in Two Kids from a Chinese Family

Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.

The adaptor Act1 is required for interleukin 17–dependent signaling associated with autoimmune and inflammatory disease

New concepts in the management of asthma.

Elucidating The Role Of Interleukin-17f In Cutaneous T-Cell Lymphoma

HDAC inhibitors modulate innate immune responses to micro-organisms relevant to chronic mucocutaneous candidiasis

Skin Microbiome Imbalance in Patients with STAT1/STAT3 Defects Impairs Innate Host Defense Responses

Intrinsic Abnormalities of Keratinocytes Initiate Skin Inflammation Through the IL-23/T17 Axis in a MALT1-Dependent Manner.

Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria

A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis

Novel STAT1 mutation in a paediatric case of chronic mucocutaneous candidiasis complicated by primary hypothyroidism: clinical presentation, genetic analysis and prognostic implications

CARD9 Mutations Linked to Subcutaneous Phaeohyphomycosis and TH17 Cell Deficiencies.